0001209191-23-059365.txt : 20231220
0001209191-23-059365.hdr.sgml : 20231220
20231220165635
ACCESSION NUMBER: 0001209191-23-059365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231218
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Noci Darlene
CENTRAL INDEX KEY: 0001862148
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40671
FILM NUMBER: 231501967
MAIL ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvalent, Inc.
CENTRAL INDEX KEY: 0001861560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 508-446-2272
MAIL ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-18
0
0001861560
Nuvalent, Inc.
NUVL
0001862148
Noci Darlene
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
0
1
0
0
Chief Development Officer
0
Class A Common Stock
2023-12-18
4
M
0
22601
1.08
A
22601
D
Class A Common Stock
2023-12-18
4
M
0
11560
6.89
A
34161
D
Class A Common Stock
2023-12-18
4
M
0
5839
14.40
A
40000
D
Class A Common Stock
2023-12-18
4
S
0
40000
75.82
D
0
D
Stock Option (Right to Buy)
1.08
2023-12-18
4
M
0
22601
0.00
D
2031-02-15
Class A Common Stock
22601
46201
D
Stock Option (Right to Buy)
6.89
2023-12-18
4
M
0
11560
0.00
D
2031-04-29
Class A Common Stock
11560
14791
D
Stock Option (Right to Buy)
14.40
2023-12-18
4
M
0
5839
0.00
D
2032-08-01
Class A Common Stock
5839
44161
D
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.40 to $76.36, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
The shares underlying this option vest as follows: 25% of the shares vested on January 11, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
The shares underlying this option vest as follows: 25% of the shares vested on April 29, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
The shares underlying this option vest as follows: 25% of the shares vested on August 1, 2023, and the remainder have vested or shall vest over the next three years in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
/s/ Deborah A. Miller, attorney-in-fact
2023-12-20